Literature DB >> 8472350

Enzyme immunoassay for intact human insulin in serum or plasma.

L Andersen1, B Dinesen, P N Jørgensen, F Poulsen, M E Røder.   

Abstract

We describe an enzyme-linked two-site immunoassay for quantitation of intact insulin in human serum and plasma. The method uses two murine monoclonal antibodies that bind to two different epitopes on the insulin molecule. The immunoassay is specific. Human proinsulin is not bound by the antibodies, and the binding of partially processed proinsulin intermediates is believed to be of minor clinical importance. The relative response of human, bovine, and porcine insulin is 1, 1, and 3, respectively. The assay is sensitive (detection limit 5 pmol/L), accurate (101% recovery with 50 pmol/L insulin added to samples, 95% with 100 pmol/L, and 89% with 300 pmol/L), and fast (results within 3 h), and has a high analytical capacity (done in microtiter plates). The working assay range selected is 5-600 pmol/L, corresponding to a clinically useful range. Because of its specificity, this two-site immunoassay gives results that are lower than those obtained by using a competitive radioimmunoassay, both in normal individuals and in non-insulin-dependent diabetics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472350

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  99 in total

1.  Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo.

Authors:  L Getty; A E Panteleon; S D Mittelman; M K Dea; R N Bergman
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Associations of components of adult height with coronary heart disease in postmenopausal women: the British women's heart and health study.

Authors:  D A Lawlor; M Taylor; G Davey Smith; D Gunnell; S Ebrahim
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

3.  Correlation between serum and plasma antibody titers to mycobacterial antigens.

Authors:  Michael Siev; Xian Yu; Rafael Prados-Rosales; Frank T Martiniuk; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

4.  Myocardial insulin resistance in patients with syndrome X.

Authors:  H E Botker; N Moller; O Schmitz; J P Bagger; T T Nielsen
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

5.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

6.  Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function.

Authors:  Sara K Hansen; Marcelina Párrizas; Maria L Jensen; Stepanka Pruhova; Jakob Ek; Sylvia F Boj; Anders Johansen; Miguel A Maestro; Francisca Rivera; Hans Eiberg; Michal Andel; Jan Lebl; Oluf Pedersen; Jorge Ferrer; Torben Hansen
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy.

Authors:  H Vestergaard; H H Klein; T Hansen; J Müller; F Skovby; C Bjørbaek; M E Røder; O Pedersen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  A sensitive and reliable method for assaying true human insulin without interaction with human proinsulin-like molecules.

Authors:  L D Monti; E P Sandoli; V C Phan; P M Piatti; S Costa; A Secchi; G Pozza
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

9.  Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.

Authors:  Jonathan Montomoli; Peter Holland-Fischer; Giampaolo Bianchi; Henning Grønbaek; Hendrik Vilstrup; Giulio Marchesini; Marco Zoli
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

10.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.